Cargando…

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention

BACKGROUND: The relation between monocyte to high-density lipoprotein cholesterol ratio (MHR) and coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. The present study aims to assess the prognostic value of MHR in patients with CAD who underwent P...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ting-Ting, Zheng, Ying-Ying, Chen, You, Yu, Zi-Xiang, Ma, Yi-Tong, Xie, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805452/
https://www.ncbi.nlm.nih.gov/pubmed/31640740
http://dx.doi.org/10.1186/s12944-019-1116-2
_version_ 1783461387873288192
author Wu, Ting-Ting
Zheng, Ying-Ying
Chen, You
Yu, Zi-Xiang
Ma, Yi-Tong
Xie, Xiang
author_facet Wu, Ting-Ting
Zheng, Ying-Ying
Chen, You
Yu, Zi-Xiang
Ma, Yi-Tong
Xie, Xiang
author_sort Wu, Ting-Ting
collection PubMed
description BACKGROUND: The relation between monocyte to high-density lipoprotein cholesterol ratio (MHR) and coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. The present study aims to assess the prognostic value of MHR in patients with CAD who underwent PCI. METHODS: A total of 673 CAD patients were retrospectively enrolled and divided into four groups according to MHR values. Multivariate Cox regression analysis was performed to study the effects of different variables to clinical outcomes reported as major adverse cardiac events (MACE) and all-cause mortality (ACM). RESULTS: In a multivariate Cox analysis, after adjustment of other confounders, MHR was found to be an independent predictor of ACM (HR: 3.655; 95% CI: 1.170–11.419, P = 0.026) and MACE (HR =2.390, 95% CI 1.379–4.143, p < 0.002). Having a MHR in the third and fourth quartile were associated with a 2.83-fold and 3.26 -flod increased risk of MACE. CONCLUSIONS: MHR is an independent predictor of ACM and MACE in CAD patients undergoing PCI.
format Online
Article
Text
id pubmed-6805452
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68054522019-10-24 Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention Wu, Ting-Ting Zheng, Ying-Ying Chen, You Yu, Zi-Xiang Ma, Yi-Tong Xie, Xiang Lipids Health Dis Research BACKGROUND: The relation between monocyte to high-density lipoprotein cholesterol ratio (MHR) and coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains controversial. The present study aims to assess the prognostic value of MHR in patients with CAD who underwent PCI. METHODS: A total of 673 CAD patients were retrospectively enrolled and divided into four groups according to MHR values. Multivariate Cox regression analysis was performed to study the effects of different variables to clinical outcomes reported as major adverse cardiac events (MACE) and all-cause mortality (ACM). RESULTS: In a multivariate Cox analysis, after adjustment of other confounders, MHR was found to be an independent predictor of ACM (HR: 3.655; 95% CI: 1.170–11.419, P = 0.026) and MACE (HR =2.390, 95% CI 1.379–4.143, p < 0.002). Having a MHR in the third and fourth quartile were associated with a 2.83-fold and 3.26 -flod increased risk of MACE. CONCLUSIONS: MHR is an independent predictor of ACM and MACE in CAD patients undergoing PCI. BioMed Central 2019-10-22 /pmc/articles/PMC6805452/ /pubmed/31640740 http://dx.doi.org/10.1186/s12944-019-1116-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wu, Ting-Ting
Zheng, Ying-Ying
Chen, You
Yu, Zi-Xiang
Ma, Yi-Tong
Xie, Xiang
Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
title Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
title_full Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
title_fullStr Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
title_full_unstemmed Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
title_short Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
title_sort monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805452/
https://www.ncbi.nlm.nih.gov/pubmed/31640740
http://dx.doi.org/10.1186/s12944-019-1116-2
work_keys_str_mv AT wutingting monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention
AT zhengyingying monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention
AT chenyou monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention
AT yuzixiang monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention
AT mayitong monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention
AT xiexiang monocytetohighdensitylipoproteincholesterolratioaslongtermprognosticmarkerinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryintervention